Loading…
Loading the latest PSX data…
Loading the latest PSX data…
Haleon Pakistan Limited (HALEON), GlaxoSmithKline Pakistan Limited (GLAXO): performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-11
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | HALEONPharmaceuticals | GLAXOPharmaceuticals |
|---|---|---|
| danioPSX score | 65 | 89 |
| Price and size | ||
| Price | Rs 689.69 | Rs 339.59 |
| Today | −1.06% | +0.96% |
| Market cap | Rs 80.7bn | Rs 108.1bn |
| Traded per day | Rs 20m | Rs 49m |
| Valuation and dividends | ||
| P/E | 12.4 | 9.9 |
| Dividend yield | 3.6% | 6.1% |
| EPS (last year) | Rs 54.45 | Rs 31.48 |
| Business | ||
| EPS growth | +39.2% | +53.4% |
| Sales growth | +15.9% | +7.7% |
| Net margin | 14.8% | 15.2% |
| Returns | ||
| 1 month | +1.7% | +8.9% |
| 3 months | −7.6% | −1.6% |
| 1 year | −15.7% | −13.9% |
| vs KSE-100, 1 year | -28.8 pts | -27.0 pts |
| Trend and risk | ||
| 52-week position | 11% | 28% |
| RSI 14 | 55 | 65 |
| RS rank | 27 | 42 |
| Volatility | 30% | 34% |
| Beta | 0.86 | 1.05 |
| danioPSX score | ||
| Value | 42 | 69 |
| Quality | 79 | 81 |
| Dividend | 45 | 64 |
| Momentum | 26 | 40 |
| Safety | 78 | 80 |
| Shariah-compliant | Yes | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener